New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives
Endocrine therapy that blocks estrogen receptor signaling has been effective for decades as a primary treatment choice for breast cancer patients expressing the estrogen receptor. However, the issue of drug resistance poses a significant clinical challenge. It is therefore critically important to cr...
Saved in:
| Main Authors: | Jian Min, Xin Liu, Rouming Peng, Chun-Chi Chen, Wei Wang, Rey-Ting Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Compuscript Ltd
2024-02-01
|
| Series: | Acta Materia Medica |
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Aryl Hydrocarbon Receptor and Crosstalk with Estrogen Receptor in Response of Breast Cancer Cells to the Novel Antitumor Agents Benzothiazoles and Aminoflavone
by: Mariana A. Callero, et al.
Published: (2011-01-01) -
Role of Estrogen Receptor Signaling in Breast Cancer Metastasis
by: Sudipa Saha Roy, et al.
Published: (2012-01-01) -
Progress of estrogen receptor and spliceosome in endometrial carcinoma
by: Ziqi Hong, et al.
Published: (2025-08-01) -
Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer
by: Zhengjia Lu, et al.
Published: (2025-06-01) -
Estrogen Receptor Expression in Tumors Different from Breast Cancer
by: T. A. Bogush, et al.
Published: (2020-05-01)